COVID-19 News Coverage
DOM In the News
Read about how the Department of Medicine is responding to the outbreak of the coronavirus respiratory illness COVID-19. See related COVID-19 publications.
New coronavirus subvariant Arcturus is now in L.A. Is there reason to worry?
Los Angeles Times |
Peter Chin-Hong spoke to the LA Times about the rise of Covid-19 infections due to the new variant known as Arcturus.
UCSF Infectious Disease Specialist on New COVID Study
NBC Bay Area |
Peter Chin-Hong appeared on NBC Bay Area News sharing insight about a new study that shows Covid-19 can be transmitted from a mother to her baby.
What to Know About the New XBB.1.16 COVID-19 Variant
TIME |
Monica Gandhi was quoted in Time Magazine discussing a new Covid-19 variant circulating in India, noting there is not a high rise in hospitalizations.
Covid experts today: Eating out, masking less, even booking cruises
Washington Post |
Monica Gandhi spoke to the Washington Post revealing how the Covid vaccine has influenced her behavior at this stage in the pandemic.
If We Knew Then What We Know Now About Covid, What Would We Have Done Differently?
Wall Street Journal |
Bob Wachter was quoted by the Wall Street Journal reflecting on the clear communication and trust that was needed at the start of the pandemic.
What the 'lab leak' theory report about COVID's origins does and doesn't mean
ABC News |
Peter Chin-Hong spoke to ABC News reacting to the Department of Energy news about the origins of Covid-19, placing more importance on lessons learned and being better prepared to respond to future epidemics and pandemics.
Immunity acquired from a Covid infection is as protective as vaccination against severe illness and death, study finds
NBC News |
Bob Wachter was quoted by NBC News commenting on research that shows immunity acquired from a Covid infection provides strong, lasting protection.
Are there places you should still mask in, forever? Three experts weigh in
NPR |
Monica Gandhi and Bob Wachter spoke to NPR discussing the powerful protection the Covid vaccines offer and when to consider wearing a mask with the current state of the virus.
Recent DOM Covid-19 Publications
Lessons learned from academic medical centers’ response to the COVID-19 pandemic in partnership with the Navajo Nation
Bongiovanni T, Shamasunder S, Brown W III, Rivera Carpenter C, Pantell M, Ghali B, Harrison, JD. Lessons learned from academic medical centers’ response to the COVID-19 pandemic in partnership with the Navajo Nation. PLoS ONE. 2022 17(4): e0265945. View in: PlosOne
Tenofovir-based PrEP for Covid-19: an untapped opportunity?
DeJong C, Spinelli MA, Okochi H, Gandhi M. Tenofovir-based PrEP for Covid-19: an untapped opportunity? AIDS. 2021 Mar 11. [Epub ahead of print]. doi: 10.1097/QAD.0000000000002877. View in: PubMed
Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19
Durstenfeld MS, Sun K, Ma Y, Rodriguez F, Secemsky EA, Parikh RV, Hsue PY. Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19. AIDS. 2021 Nov 8. [Epub ahead of print]. doi: 10.1097/QAD.0000000000003129. View in: PubMed
The evolution of a hospital-based Covid-19 vaccination program for inpatients
Freiser D, Roca M, Chung T, Bhakta T, Winston LG, Ortiz GM. The evolution of a hospital-based Covid-19 vaccination program for inpatients. NEJM Catalyst Innovations in Care Delivery. Vol. 3 No. 2. February 2022. doi: 10.1056/CAT.21.0340. View in: NEJM Catalyst
Incidence of severe COVID-19 illness following vaccination and booster with BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines
Kelly JD, Leonard S, Hoggatt KJ, Boscardin WJ, Lum EN, Moss-Vazquez TA, Andino R, Wong JK, Byers A, Bravata DM, Tien PC, Keyhani S. Incidence of severe COVID-19 illness following vaccination and booster with BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines. JAMA.2022 Oct 11;328(14):1427-1437. doi: 10.1001/jama.2022.17985. View in: PubMed
Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study
Kiang MV, Chin ET, Huynh BQ, Chapman LAC, Rodríguez-Barraquer I, Greenhouse B, Rutherford GW, Bibbins-Domingo K, Havlir D, Basu S, Lo NC. Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study. Lancet Infect Dis.2021 Mar 22;S1473-3099(21)00134-1. [Epub ahead of print]. doi: 10.1016/S1473-3099(21)00134-1.View in: PubMed
IL-6 receptor antagonist therapy for patients hospitalized for COVID-19: Who, when, and how?
Matthay MA, Luetkemeyer AF. IL-6 receptor antagonist therapy for patients hospitalized for COVID-19: Who, when, and how? JAMA. 2021 Aug 10;326(6):483-485. doi: 10.1001/jama.2021.11121. View in: PubMed
Early clues regarding the pathogenesis of long-COVID
Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of long-COVID. Trends Immunol.2022 Apr;43(4):268-270. [Epub ahead of print] doi: 10.1016/ j. it.2022.02.008. View in: PubMed
Lack of antinuclear antibodies in convalescent coronavirus disease 2019 patients with persistent symptoms
Peluso MJ, Thomas IJ, Munter SE, Deeks SG, Henrich TJ. Lack of antinuclear antibodies in convalescent coronavirus disease 2019 patients with persistent symptoms. Clin Infect Dis. 2022 Jun 10;74(11):2083-2084. doi: 10.1093/cid/ciab890. View in: PubMed
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman EA, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021 08 10; 36(6):109518. View in: PubMed
How will Covid-19 transform global health post-pandemic? Defining research and investment opportunities and priorities
Reid M, Abdool-Karim Q, Geng E, Goosby E. How will Covid-19 transform global health post-pandemic? Defining research and investment opportunities and priorities. PLoS Med. 2021 Mar; 18(3):e1003564. eCollection 2021 Mar. doi: 10.1371/journal.pmed.1003564. View in: PubMed
Vaccinated but not protected — living immunocompromised during the pandemic
Ryan L. Vaccinated but not protected — living immunocompromised during the pandemic. JAMA.2021 Jun 22;325(24):2443-2444. doi: 10.1001/jama.2021.9321. View in: PubMed
Differences in post-mRNA vaccination severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) concentrations and surrogate virus neutralization test response by human immunodeficiency virus (HIV) status and type of vaccine: A matched case-control observational study
Spinelli MA, Peluso MJ, Lynch KL, Yun C, Glidden DV, Henrich TJ, Deeks SG, Gandhi M. Differences in post-mRNA vaccination severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) concentrations and surrogate virus neutralization test response by human immunodeficiency virus (HIV) status and type of vaccine: A matched case-control observational study. Clin Infect Dis. 2022 Aug 24;75(1):e916-e919. doi: 10.1093/cid/ciab1009. View in: PubMed
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Suryawanshi RK, Chen IP, Ma T, Syed AM, Brazer N, Saldhi P, Simoneau CR, Ciling A, Khalid MM, Sreekumar B, Chen PY, Kumar GR, Montano M, Gascon R, Tsou CL, Garcia-Knight MA, Sotomayor-Gonzalez A, Servellita V, Gliwa A, Nguyen J, Silva I, Milbes B, Kojima N, Hess V, Shacreaw M, Lopez L, Brobeck M, Turner F, Soveg FW, George AF, Fang X, Maishan M, Matthay M, Morris MK, Wadford D, Hanson C, Greene WC, Andino R, Spraggon L, Roan NR, Chiu CY, Doudna JA, Ott M. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature. 2022 May 18. [Epub ahead of print]. doi: 10.1038/s41586-022-04865-0. View in: PubMed
Nailing the nuance on COVID-19
Wachter RM. Nailing the nuance on COVID-19. Science. 2022 Jul 15;377(6603):243. [Epub ahead of print]. doi: 10.1126/science.add8599. View in: PubMed
The impact of the COVID-19 pandemic on internet use and use of digital health tools: A secondary analysis of the 2020 health information national trends survey
Zeng B, Rivadeneira NA, Wen A, Sarkar U, Khoong EC. The impact of the COVID-19 pandemic on internet use and use of digital health tools: A secondary analysis of the 2020 health information national trends survey. J Med Internet Res. 2022 Aug 26. [Epub ahead of print]. doi: 10.2196/35828. View in: PubMed